SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and Business Highlights
December 15, 2021
 · 
6 min read
Business
Kiora Pharmaceuticals Appoints David Hollander, MD, MBA, to its Board of Directors
December 15, 2021
 · 
4 min read
Pharm Country
Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed Pharmaceutics
December 14, 2021
 · 
4 min read
Business
Awakn Life Sciences Appoints Former EVP & Chief Commercial Officer of Gilead Sciences, Paul Carter, as Independent Member of its Board of Directors
December 14, 2021
 · 
6 min read
Drug Development
Kiora Reports KIO-101 is Safe and Tolerable; Topline Data Supports Advancing KIO-101 to a Phase 2 Study in Patients with Dry Eye Disease
December 14, 2021
 · 
5 min read
Business
Mycrodose Therapeutics Expands Scientific Advisory Board with the Addition of Dr. Yavorsky and Dr. Jacques
December 14, 2021
 · 
4 min read
Pacylex Presented Initial Clinical Experience With PCLX-001 in Patients at ASH 2021
December 13, 2021
 · 
2 min read
Defence Therapeutics Accum(TM) Boosts by 9-Fold the Delivery Effectiveness of the CRISPR/Cas9 Protein to Target Cells
December 13, 2021
 · 
4 min read
Hemostemix Announces Soft Lock of Database as Source Document Verification Completed
December 9, 2021
 · 
6 min read
Marvel Biosciences Achieves CGMP Milestone and Begins IND-Enabling Pre-Clinical Toxicology Testing of Lead Compound
December 9, 2021
 · 
6 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us